palmidrol has been researched along with Depression in 6 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antidepressant effect of a compound formed by co-ultramicronized palmitoylethanolamide (PEA) and luteolin (PEA+luteolin) was investigated in a mouse model of anxiety/depressive-like behavior." | 7.79 | Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression. ( Ahmad, A; Campolo, M; Crupi, R; Cuzzocrea, S; Esposito, E; Paterniti, I, 2013) |
| "The antidepressant effect of a compound formed by co-ultramicronized palmitoylethanolamide (PEA) and luteolin (PEA+luteolin) was investigated in a mouse model of anxiety/depressive-like behavior." | 3.79 | Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression. ( Ahmad, A; Campolo, M; Crupi, R; Cuzzocrea, S; Esposito, E; Paterniti, I, 2013) |
| "Inflammation is fundamentally a protective cellular response aimed at removing injurious stimuli and initiating the healing process." | 2.52 | N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution. ( Barbierato, M; Bruschetta, G; Cuzzocrea, S; Facci, L; Giusti, P; Impellizzeri, D; Skaper, SD; Zusso, M, 2015) |
| "Depression is a common brain disorder affecting about 350 million people worldwide." | 1.40 | Is there a role for palmitoylethanolamide in the treatment of depression? ( Coppola, M; Mondola, R, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Stensson, N | 1 |
| Gerdle, B | 1 |
| Ernberg, M | 1 |
| Mannerkorpi, K | 1 |
| Kosek, E | 1 |
| Ghafouri, B | 1 |
| Crupi, R | 1 |
| Paterniti, I | 1 |
| Ahmad, A | 1 |
| Campolo, M | 1 |
| Esposito, E | 1 |
| Cuzzocrea, S | 2 |
| Coppola, M | 1 |
| Mondola, R | 1 |
| Skaper, SD | 1 |
| Facci, L | 1 |
| Barbierato, M | 1 |
| Zusso, M | 1 |
| Bruschetta, G | 1 |
| Impellizzeri, D | 1 |
| Giusti, P | 1 |
| Yu, HL | 1 |
| Deng, XQ | 1 |
| Li, YJ | 1 |
| Li, YC | 1 |
| Quan, ZS | 1 |
| Sun, XY | 1 |
| Heyman, E | 1 |
| Gamelin, FX | 1 |
| Goekint, M | 1 |
| Piscitelli, F | 1 |
| Roelands, B | 1 |
| Leclair, E | 1 |
| Di Marzo, V | 1 |
| Meeusen, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Training and Relaxation on Fibromyalgia.[NCT01226784] | 240 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for palmidrol and Depression
| Article | Year |
|---|---|
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
Topics: Administration, Oral; Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Antidepressive Age | 2015 |
5 other studies available for palmidrol and Depression
| Article | Year |
|---|---|
Increased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia.
Topics: Amides; Anxiety; Arachidonic Acids; Depression; Endocannabinoids; Ethanolamines; Exercise Therapy; F | 2020 |
Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression.
Topics: Amides; Animals; Antidepressive Agents; Anxiety; Apoptosis; Behavior, Animal; Brain; Brain-Derived N | 2013 |
Is there a role for palmitoylethanolamide in the treatment of depression?
Topics: Amides; Depression; Endocannabinoids; Ethanolamines; Humans; Models, Theoretical; Palmitic Acids | 2014 |
N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice.
Topics: Administration, Oral; Amides; Animals; Antidepressive Agents; Cannabinoid Receptor Modulators; Depre | 2011 |
Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.
Topics: Adult; Amides; Arachidonic Acids; beta-Endorphin; Bicycling; Brain-Derived Neurotrophic Factor; Cann | 2012 |